{"id":5885,"date":"2024-04-30T14:40:55","date_gmt":"2024-04-30T14:40:55","guid":{"rendered":"https:\/\/aceoncology.org\/?post_type=ace_education&#038;p=5885"},"modified":"2024-06-12T20:48:19","modified_gmt":"2024-06-12T20:48:19","slug":"best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2","status":"publish","type":"ace_education","link":"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/","title":{"rendered":"Session 2: Maximizing the survival benefit through a sequential treatment strategy in locally advanced or metastatic urothelial cancer"},"content":{"rendered":"\n<p>The increasing availability of treatment options in the first-line (1L) setting after ESMO 2023 has led to a growing complexity in determining sequential treatment strategies for different clinical scenarios following progression of 1L therapies. In this educational program on &#8216;Best Practice Exchange in Clinical Case Scenarios&#8217;, field experts will discuss the latest evidence supporting the optimal utilization of sequential treatments, including immunotherapy, chemotherapy (CT), antibody-drug conjugates (ADCs), and targeted therapies, to prolong continuum of care and maximize survival benefits for patients. A better understanding of how to sequence available options for second-line (2L) and salvage treatments in routine patient care will facilitate optimal management of urothelial cancer patients.<\/p>\n\n\n\n<div style=\"height:9px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>This English program is available with subtitles in the following languages:<\/p>\n\n\n\n<div style=\"height:5px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2023\/05\/Screenshot-2023-05-10-144115.png\" alt=\"This image has an empty alt attribute; its file name is Screenshot-2023-05-10-144115.png\"\/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>The increasing availability of treatment options in the [&hellip;]<\/p>\n","protected":false},"author":719,"featured_media":5856,"template":"","ace_education_category":[101,68],"ace_education_tag":[],"class_list":["post-5885","ace_education","type-ace_education","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Session 2: Maximizing the survival benefit through a sequential treatment strategy in locally advanced or metastatic urothelial cancer - ACE Oncology<\/title>\n<meta name=\"description\" content=\"Maximizing the survival benefit through a sequential treatment strategy\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Session 2: Maximizing the survival benefit through a sequential treatment strategy in locally advanced or metastatic urothelial cancer - ACE Oncology\" \/>\n<meta property=\"og:description\" content=\"Maximizing the survival benefit through a sequential treatment strategy\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/\" \/>\n<meta property=\"og:site_name\" content=\"ACE Oncology\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-12T20:48:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2024\/03\/Best-Practice-Exchange-edu-600x400-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:label1\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/\",\"url\":\"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/\",\"name\":\"Session 2: Maximizing the survival benefit through a sequential treatment strategy in locally advanced or metastatic urothelial cancer - ACE Oncology\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2024\/03\/Best-Practice-Exchange-edu-600x400-1.jpg\",\"datePublished\":\"2024-04-30T14:40:55+00:00\",\"dateModified\":\"2024-06-12T20:48:19+00:00\",\"description\":\"Maximizing the survival benefit through a sequential treatment strategy\",\"breadcrumb\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/#primaryimage\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2024\/03\/Best-Practice-Exchange-edu-600x400-1.jpg\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2024\/03\/Best-Practice-Exchange-edu-600x400-1.jpg\",\"width\":600,\"height\":400},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"ACE Oncology\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u5728\u7ebf\u6559\u80b2\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/education\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Session 2: Maximizing the survival benefit through a sequential treatment strategy in locally advanced or metastatic urothelial cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/aceoncology.org\/#website\",\"url\":\"https:\/\/aceoncology.org\/\",\"name\":\"ACE Oncology\",\"description\":\"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.\",\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/aceoncology.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/aceoncology.org\/#organization\",\"name\":\"ACE Oncology\",\"url\":\"https:\/\/aceoncology.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"width\":156,\"height\":83,\"caption\":\"ACE Oncology\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ace_oncology\",\"https:\/\/www.linkedin.com\/company\/aceoncology\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Session 2: Maximizing the survival benefit through a sequential treatment strategy in locally advanced or metastatic urothelial cancer - ACE Oncology","description":"Maximizing the survival benefit through a sequential treatment strategy","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/","og_locale":"zh_CN","og_type":"article","og_title":"Session 2: Maximizing the survival benefit through a sequential treatment strategy in locally advanced or metastatic urothelial cancer - ACE Oncology","og_description":"Maximizing the survival benefit through a sequential treatment strategy","og_url":"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/","og_site_name":"ACE Oncology","article_modified_time":"2024-06-12T20:48:19+00:00","og_image":[{"width":600,"height":400,"url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2024\/03\/Best-Practice-Exchange-edu-600x400-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@ace_oncology","twitter_misc":{"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/","url":"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/","name":"Session 2: Maximizing the survival benefit through a sequential treatment strategy in locally advanced or metastatic urothelial cancer - ACE Oncology","isPartOf":{"@id":"https:\/\/aceoncology.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/#primaryimage"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2024\/03\/Best-Practice-Exchange-edu-600x400-1.jpg","datePublished":"2024-04-30T14:40:55+00:00","dateModified":"2024-06-12T20:48:19+00:00","description":"Maximizing the survival benefit through a sequential treatment strategy","breadcrumb":{"@id":"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/#primaryimage","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2024\/03\/Best-Practice-Exchange-edu-600x400-1.jpg","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2024\/03\/Best-Practice-Exchange-edu-600x400-1.jpg","width":600,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/aceoncology.org\/zh-hans\/education\/best-practice-exchange-in-clinical-case-scenarios-learning-from-experts-on-urothelial-cancer-session-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"ACE Oncology","item":"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/"},{"@type":"ListItem","position":2,"name":"\u5728\u7ebf\u6559\u80b2","item":"https:\/\/aceoncology.org\/zh-hans\/education\/"},{"@type":"ListItem","position":3,"name":"Session 2: Maximizing the survival benefit through a sequential treatment strategy in locally advanced or metastatic urothelial cancer"}]},{"@type":"WebSite","@id":"https:\/\/aceoncology.org\/#website","url":"https:\/\/aceoncology.org\/","name":"ACE Oncology","description":"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.","publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aceoncology.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/aceoncology.org\/#organization","name":"ACE Oncology","url":"https:\/\/aceoncology.org\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","width":156,"height":83,"caption":"ACE Oncology"},"image":{"@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ace_oncology","https:\/\/www.linkedin.com\/company\/aceoncology"]}]}},"_links":{"self":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/ace_education\/5885","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/ace_education"}],"about":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/types\/ace_education"}],"author":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/users\/719"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media\/5856"}],"wp:attachment":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media?parent=5885"}],"wp:term":[{"taxonomy":"ace_education_category","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/ace_education_category?post=5885"},{"taxonomy":"ace_education_tag","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/ace_education_tag?post=5885"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}